221 related articles for article (PubMed ID: 21659760)
21. New insights into TGF-β/Smad signaling in tissue fibrosis.
Hu HH; Chen DQ; Wang YN; Feng YL; Cao G; Vaziri ND; Zhao YY
Chem Biol Interact; 2018 Aug; 292():76-83. PubMed ID: 30017632
[TBL] [Abstract][Full Text] [Related]
22. Smad7 as a therapeutic agent for chronic kidney diseases.
Lan HY
Front Biosci; 2008 May; 13():4984-92. PubMed ID: 18508563
[TBL] [Abstract][Full Text] [Related]
23. Dencichine ameliorates kidney injury in induced type II diabetic nephropathy via the TGF-β/Smad signalling pathway.
Jie L; Pengcheng Q; Qiaoyan H; Linlin B; Meng Z; Fang W; Min J; Li Y; Ya Z; Qian Y; Siwang W
Eur J Pharmacol; 2017 Oct; 812():196-205. PubMed ID: 28633927
[TBL] [Abstract][Full Text] [Related]
24. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator.
Ziyadeh FN
J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S55-7. PubMed ID: 14684674
[TBL] [Abstract][Full Text] [Related]
25. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
26. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
[TBL] [Abstract][Full Text] [Related]
27. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway.
Yang J; Kan M; Wu GY
Immunopharmacol Immunotoxicol; 2016; 38(2):145-52. PubMed ID: 26954391
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
Chen KH; Hung CC; Hsu HH; Jing YH; Yang CW; Chen JK
Chem Biol Interact; 2011 Mar; 190(1):45-53. PubMed ID: 21300041
[TBL] [Abstract][Full Text] [Related]
30. Role of Smad signaling in kidney disease.
Zhang Y; Wang S; Liu S; Li C; Wang J
Int Urol Nephrol; 2015 Dec; 47(12):1965-75. PubMed ID: 26433882
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy.
Liu S; Wu W; Liao J; Tang F; Gao G; Peng J; Fu X; Zhan Y; Chen Z; Xu W; Zhao S
Front Endocrinol (Lausanne); 2022; 13():895010. PubMed ID: 35865316
[TBL] [Abstract][Full Text] [Related]
32. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
33. [Regulatory effect of compound Coptidis Rhizoma capsule on unbalanced expression of renal tissue TGF-β1/BMP-7 and Smad signaling pathway in rats with early diabetic nephropathy].
Liu S; Chen XQ; Tang LQ; Yu N; Zhang XL; Du HF
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):938-45. PubMed ID: 26087560
[TBL] [Abstract][Full Text] [Related]
34. Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy.
Tu Y; Wu T; Dai A; Pham Y; Chew P; de Haan JB; Wang Y; Toh BH; Zhu H; Cao Z; Cooper ME; Chai Z
Kidney Int; 2011 Jan; 79(2):199-209. PubMed ID: 20962744
[TBL] [Abstract][Full Text] [Related]
35. Samchuleum attenuates diabetic renal injury through the regulation of TGF‑β/Smad signaling in human renal mesangial cells.
Yoon JJ; Lee YJ; Namgung S; Han BH; Choi ES; Kang DG; Lee HS
Mol Med Rep; 2018 Feb; 17(2):3099-3108. PubMed ID: 29257237
[TBL] [Abstract][Full Text] [Related]
36. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads.
Park SH
J Biochem Mol Biol; 2005 Jan; 38(1):9-16. PubMed ID: 15715940
[TBL] [Abstract][Full Text] [Related]
37. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway.
Wicks SJ; Grocott T; Haros K; Maillard M; ten Dijke P; Chantry A
Biochem Soc Trans; 2006 Nov; 34(Pt 5):761-3. PubMed ID: 17052192
[TBL] [Abstract][Full Text] [Related]
38. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
[TBL] [Abstract][Full Text] [Related]
39. TGF-β/Smad and Renal Fibrosis.
Ma TT; Meng XM
Adv Exp Med Biol; 2019; 1165():347-364. PubMed ID: 31399973
[TBL] [Abstract][Full Text] [Related]
40. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes.
Roman-Blas JA; Stokes DG; Jimenez SA
Osteoarthritis Cartilage; 2007 Dec; 15(12):1367-77. PubMed ID: 17604656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
